NSE filing, NSE: NATCOPHARM. Summary written from the filing by ALFA Finder's alert engine.
Natco Pharma Ltd: key numbers
- Share price
- ₹787.00
- Market cap
- ₹15,438 Cr
- Revenue (annual)
- ₹4,078 Cr
- Net profit (annual)
- ₹1,418 Cr
- P/E (TTM)
- 13.5×Sector 46.1×
- Promoter holding
- 49.39%-0.03% QoQ
- FII holding
- 15.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natco Pharma Ltd
All →Natco Pharma Employee Stock Options
Natco Pharma's insiders, including promoters and directors, were allotted equity shares. This allotment increases their total shareholding in the company.
- Value
- ₹144.2 Cr
Natco Pharma Capital Structure Change
Natco Pharma's ₹1,279.4 Crore rights issue closed on October 22, 2026. Shares were priced at ₹750 each on a ₹2 face value.
- Value
- ₹1,279 Cr
Natco Pharma Product Launch
Natco Pharma launches Carboplatin Injection, a Paraplatin® generic, in the U.S. market via its subsidiary. The oncology product addresses a critical U.S. supply shortage.
Natco Pharma Other Announcement
Natco Pharma Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance submission.
Natco Pharma Share Pledge
Promoter V.C. Nannapaneni pledged 850,000 shares of Natco Pharma, valued at ₹67.10 Crore. This pledge creation increases encumbrance on promoter shareholding.
- Value
- ₹67.10 Cr
Natco Pharma Fund Raise of ₹2,000 Cr
Natco Pharma shareholders approved fund raising of up to Rs. 2,000 Crore through various instruments, along with other routine AGM resolutions.
- Value
- ₹2,000 Cr
Other board meeting date announcements
All →Panasonic Energy India Company Board Meeting Date
Panasonic Energy India schedules a board meeting on 5 November 2026 to approve unaudited quarterly and six-month results. Trading window stays closed until 48 hours after the results declaration.
Torrent Power Board Meeting Date
Torrent Power schedules a board meeting on 4 November 2026 to approve unaudited standalone and consolidated results for Q2 and half year. The notice carries no financial figures.
Vascon Engineers Board Meeting Date
Vascon Engineers has scheduled a board meeting on November 3, 2026 for quarterly results and NCD fund raising. Trading window stays closed until results are declared.
Ruchi Infrastructure Board Meeting Date
Ruchi Infrastructure schedules a board meeting on 4 November 2026 to approve unaudited quarterly and half-year results. Trading window remains closed until 6 November 2026.
Swastika Castal Board Meeting Date
Swastika Castal will hold a board meeting on 4 November 2026 to consider unaudited results for period ended 30 September 2026. Trading window stays closed until results.
GTL Board Meeting Date
GTL Ltd will hold a board meeting on 5 November 2026 to consider unaudited results for quarter ended 30 September 2026. Results are proposed until the meeting.